论文部分内容阅读
目的探讨环孢素A(CyA)在合并糖尿病的免疫性血小板减少性紫癜(ITP)治疗中临床疗效。方法免疫性血小板减少性紫癜合并糖尿病患者15例,予以环孢素A5mg/kg/d,3次/d口服,连续应用3个月,有效者原量应用3个月,逐渐减量维持,无效者停用,观察治疗过程中及6个月后血小板计数,评定疗效。结果 1例治疗15天因经济原因停药,2例因肝功受损停药,1例1个月后失随访,11例完成6个月治疗,其中良效7例(63.6%),显效2例(18.2%),无效2例(18.2%),有效率81.8%。结论环孢素A对合并糖尿病ITP患者的治疗疗效满意。
Objective To investigate the clinical efficacy of cyclosporine A (CyA) in the treatment of immune thrombocytopenic purpura (ITP) with diabetes mellitus. Methods Fifteen patients with immune thrombocytopenic purpura complicated with diabetes were treated with cyclosporine A5mg / kg / d orally for 3 times daily for 3 months. The effective volume of the effective dose was maintained for 3 months, Were disabled, observe the course of treatment and 6 months after platelet count, assess the efficacy. Results One case was discontinued on economic grounds for 15 days, two cases were discontinued due to liver damage, one case lost follow-up after one month and 11 cases completed 6 months treatment. Among them, 7 cases (63.6%) were good and effective 2 cases (18.2%), 2 cases (18.2%) were ineffective, and the effective rate was 81.8%. Conclusion Cyclosporine A is effective in treating ITP patients with diabetes mellitus.